Annibale Versari

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 515 citations · Full text

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

John Raemaekers, Marc André, Massimo Federico et al. · Journal of Clinical Oncology · 2014 · 381 citations · Full text

Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies

Michel Meignan, Anne‐Ségolène Cottereau, Annibale Versari et al. · Journal of Clinical Oncology · 2016 · 325 citations · Full text

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

Andrea Gallamini, Luigi Rigacci, Francesco Merli et al. · PubMed · 2006 · 294 citations

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

Myriam Sasanelli, Michel Meignan, Corinne Haïoun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 232 citations

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +11